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Featured Application: This manuscript seeks an extensive and comprehensive review of the liter-
ature on the complexity of chronic wounds, highlighting therapeutic wound dressings and pro-
viding an overview of the biological potential of polyphenolic agents as natural antimicrobials
and the strategies to stabilize and release them in the treatment of complex wounds.
Abstract: In chronic wounds, the regeneration process is compromised, which brings complexity
to the therapeutic approaches that need to be adopted, while representing an enormous loss in the
patients’ quality of life with consequent economical costs. Chronic wounds are highly prone to
infection, which can ultimately lead to septicemia and morbidity. Classic therapies are increasing
antibiotic resistance, which is becoming a critical problem beyond complex wounds. Therefore,
it is essential to study new antimicrobial polymeric systems and compounds that can be effective
alternatives to reduce infection, even at lower concentrations. The biological potential of polyphenols
allows them to be an efficient alternative to commercial antibiotics, responding to the need to find
new options for chronic wound care. Nonetheless, phenolic compounds may have some drawbacks
when targeting wound applications, such as low stability and consequent decreased biological
performance at the wound site. To overcome these limitations, polymeric-based systems have been
developed as carriers of polyphenols for wound healing, improving its stability, controlling the
release kinetics, and therefore increasing the performance and effectiveness. This review aims to
highlight possible smart and bio-based wound dressings, providing an overview of the biological
potential of polyphenolic agents as natural antimicrobial agents and strategies to stabilize and deliver
them in the treatment of complex wounds. Polymer-based particulate systems are highlighted here
due to their impact as carriers to increase polyphenols bioavailability at the wound site in different
types of formulations.
Keywords: polymer; polyphenols; nano/microencapsulation; infection; wound healing and regeneration
1. Introduction
Despite all the driven technological advances in the management and treatment of
chronic wounds, these remain a challenge for clinicians and researchers worldwide due to
the complexity of healing that often fails to progress.
The wound healing process consists of a cascade of coordinated events after a skin
injury, trauma, or laceration, which is followed by the natural regeneration of the skin’s
protective barrier. In a chronic wound, the healing stages progress for more than three
months and are characterized by a prolonged and sustained inflammatory phase that
prevents dermal and epidermal cells from responding to chemical signals [1]. The increase
in the elderly population, combined with the risk of comorbidities, such as diabetes and
vascular problems, may cause chronic wounds to be a significant contributor to health
costs and morbidity [1]. In these cases, blood flow can be injured, which leads to persistent
chronic wounds that do not heal and are prominent to infection and septicemia.
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There are more than 6.5 million patients affected by the chronic wound, and the cost
of treatment is estimated to be USD 25 billion per year [2]. Chronic wounds translate into
an economic burden on the health system due to increased costs with dressing changes,
hospitalizations, and nursing care. Moreover, the price of wound care products in the
international market was estimated at USD 19.8 billion in 2019 and is expected to reach
USD 24.8 billion by 2024 [3]. Therefore, the development of wound care is recently focused
on biopolymers, which have become preferred candidates used in wound dressing appli-
cations due to their biocompatibility, biodegradability, non-toxicity, and ability to absorb
bioactive molecules [4]. The need for more biomimetic approaches has powered the explo-
ration of numerous emerging bio-based technologies. Nevertheless, the development of
new therapies requires extensive knowledge of the wound healing process, stages, and the
key players involved.
This review seeks to bring researchers an updated description of the wound healing
process, combining the wide variety of polyphenols-based strategies for accelerating wound
healing—from systemic or local dressing to cell-free therapies in nano/microsystems.
2. Wound Healing
Wound healing is a highly accurate and well-orchestrated process that repairs and
regenerates the damaged tissue after the onset of a lesion, where the physical continuity
of functional tissues is disintegrated [5]. Therefore, physiologic wound healing proceeds
through a defined sequence of specific phases that involve high coordination between cell
types and several tissues. However, a simple anomaly at any step can disrupt the healing
process and, consequently, compromise the wound closure [2,6,7]. Some disorders, such as
diabetes, tobacco abuse, aging, obesity, or sensory neuropathies, constitute some of the
reasons that contribute to the disruption of the healing process [7,8]. Depending on the
impairment and at what phase of the process it occurs, wound healing can be significantly
delayed, which can give rise to acute or even chronic wounds [2,5]. Moreover, as a
consequence of an impaired wound-closure, the increase in wound exposure can lead
to serious infections [9]. Hereupon, concepts of normal and impaired wound healing
are described, in addition to current practice therapies and their challenges for chronic
wound care. The potential of bioactive compounds and delivery systems is discussed as
a promising avenue in smart bio-based therapeutic solutions.
2.1. Chronic Wounds: The Impaired Healing
Chronic wounds are characterized by an impaired healing process caused by different
factors, both external and internal. There are different types of chronic wounds, namely,
vascular ulcers (venous and arterial). Even though the term “chronicity” and the timeframe
for the healing process are not clearly pre-established, it is estimated that the impaired
physiologic process can take more than six weeks [2,10,11]. The long healing process that
significantly affects the patient’s quality of life is a significant cause of morbidity due to
serious infections and ulceration and leads to amputations, such as in the case of diabetic
foot ulcers [12]. Nowadays, the issue relative to chronic wounds leads to approximately
40 million chronic wound patients worldwide, causing an enormous economic impact on
healthcare systems [8]. An increase of more than 44% is envisaged for 2023, in respect of
2016 [8]. Based on these statistical data, adequate and well-planned management of chronic
wounds has achieved increasing importance [2]. In order to improve human quality of
life, a deeper knowledge of the healing process and the development of new alternatives
for chronic wound treatment have raised great interest in the scientific community [6,8].
Therefore, it is a priority to understand the normal and insufficient healing process.
In healthy people, wound healing is a fascinating biological process, composed of
four main basic phases, including hemostasis, inflammatory, proliferative, and remodeling
(Figure 1).
Appl. Sci. 2021, 11, 1230 3 of 20
Appl. Sci. 2021, 11, x FOR PEER REVIEW 3 of 20 
 
In healthy people, wound healing is a fascinating biological process, composed of 
four main basic phases, including hemostasis, inflammatory, proliferative, and remodel-
ing (Figure 1). 
 
Figure 1. Different phases of normal wound healing. 
The hemostasis phase is characterized by current platelet activation, which results in 
releasing chemokines and growth factors to form the clot [13]. When the coagulation is 
complete, the platelet is reinforced with a fibrin network acting as a molecular binding 
agent to form a barrier against microorganisms and organize the matrix for cell migration. 
In response to inflammatory signs, phagocytes (neutrophils and macrophages) migrate to 
the wound, facilitating phagocytosis of bacteria and damaged tissue [5,13]. Both cells are 
responsible for the production of cytokines and growth factors, which are necessary for 
an efficient wound healing process [14]. Before the proliferative phase, macrophages are 
responsible for the release of cytokines and residual neutrophils by apoptosis, which al-
lows the healing process to proceed. In response to growth factors, the wound closure is 
also characterized by the deposition of collagen fibers produced by the migration of fibro-
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with new tissue formed by extracellular matrix (granulation tissue). Thus, granulation tis-
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The hemostasis phase is characterized by current platelet activation, which results in
relea ing chemokines and growth factors to form he clot [13]. W en the coagulation is
complete, the platelet is reinforced with a fibrin network acting as a molecular binding
agent to form a barrier against microorganisms and organize the matrix for cell migration.
In response to inflammatory signs, phagocytes (neutrophils and macrophages) migrate to
the wound, facilitating phagocytosis of bacteria and damaged tissue [5,13]. Both cells are
responsible for the production of cytokines and growth factors, which are necessary for
an efficient wound healing process [14]. Before the proliferative phase, macrophages are
responsible for the release of cytokines and residual neutrophils by apoptosis, which allows
the healing process to proceed. In res onse to growt factors, the wound closure is
also char cterized by the deposition of collagen fibers produced by the migration of
fibroblasts to promote the production of extracellular matrix [5]. Additionally, macrophages
are responsible for stimulating the formation of new blood vessels at the wound brim
(angiogenesis), providing oxygen, nutrients, and metabolite, and rebuilding the initial clot
with new tissue formed by extracellular matrix (granulation tissue). Thus, granulation
tissue creates the conditions needed for re-epithelialization [13]. Finally, the remodeling
phase is characterized by the resynthesis of the extracellular matrix, which is necessary
for creating a balance between apoptosis of existing cells and production of new cells.
This phase begins when the collagen is remodeled from type III of the granulatio tissue to
type I and becomes aligned n parall l bundl s, which increase t e ten ile strength and the
wound fully closes [13,14].
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However, chronic wounds are characterized by a significant delay in the repair of
the anatomical integrity of the wound [11]. The impaired wound healing is characterized
by an interruption of the physiological process in the inflammatory phase, difficult re-
epithelization, disorder levels of growth factors, and/or impaired angiogenesis. All these
abnormalities that occur in chronic wounds give rise to different functional disturbances at
a cellular level [15]. A schematic representation of the chronic wound healing process is
presented in Figure 2.
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The impaired wound healing of chronic wounds is also characterized by a disar-
ranged conversio of monocytes into macrophages t t hamper the inflammatory phase
because the surrou ding tissue is destructed. In addition, the function of macrophages
to clear apoptotic neutrophils by phagocytosis is decreased, resulting in a persistent of
neutrophils, which can lead to lower antibacterial activity and, consequently, to aberrant
repair [8,9]. This influx of neutrophils is responsible for the release for the overproduction
of free radicals and reactive oxygen species (ROS), such as hydrogen peroxide (H2O2) and
superoxide (O2) [8,16]. Due to an unpaired electron in the outermost shell of the nucleus,
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these species are reactive with high affinity either to donate or obtain electrons from another
species to gain stability [13,16,17]. The skin has its own defense mechanisms to combat
that oxidative stress, such as enzymes, vitamins, and chelating agents, which keep ROS
at very low levels. Nonetheless, the persistence of neutrophils during the hemostasis and
inflammatory phases significantly affects wound healing by inducing oxidative stress in
chronic wounds [18]. As a result, the production of compounds of extracellular matrix or
even growth factors can be affected, compromising the normal cell function. Furthermore,
there is a decrease in fibroblasts migration to the wound site and a disability to respond to
inflammatory mediators and growth factors, resulting in a dysfunctional epithelialization
and an impaired angiogenic response [19,20]. In addition, there is also an impaired collagen
accumulation [13,16,17].
Moreover, there are some controllable extrinsic factors that can also aggravate the
chronic wound healing process. As an example, poor nutrition can be responsible for
reducing the proliferation of fibroblasts and the synthesis of collagen. Cigarette smoking,
alcohol consumption, depression and anxiety, and even disturbed sleeping are also other
factors that contribute to the development of chronic wounds [15,21]. All these intrinsic
and extrinsic factors associated with the impaired healing of chronic wounds negatively
affect extracellular matrix deposition, host immune response, and access to antibiotics to
the wound site in case of infection [22].
2.2. Prominent Infection and Healing—Current Treatments
Prominent infections are often mentioned as the most common impediment to wound
healing, especially in the case of chronic wounds. As already mentioned, chronic wounds
are highly prone to develop serious infections given that an open wound is a favorable
niche for microbial colonization [15]. Wound infection is characterized by the colonization
of pathogenic microorganisms, usually bacteria, capable of developing colonies in the
wound site. Consequently, while the healing process is delayed, the wound becomes
increasingly impenetrable by the antimicrobial agents [15]. Another consequence associated
with wound infection is oxidative stress, which also retards the physiological healing
process. Chronic infections frequently require hospitalization of patients and the infection
is responsible for high rates of morbidity and mortality. Although the micro profile varies
from patient to patient, infection in chronic wounds is frequently polymicrobial. Studies
have shown that the most frequent microorganisms include Staphylococcus aureus and
methicillin-resistant S. aureus in the initial stages of chronic wounds, and Escherichia coli
and Pseudomonas aeruginosa in later stages [2,9].
There are many approaches toward the treatment of wound infections that simul-
taneously improve the healing process. The priority is to stop the progression of the
infection using antimicrobial agents such as antibiotics. Different antibiotics are available
for chronic wound treatment, but the selection of the adequate antimicrobial compound
must be pondered, based on the pathogenic organisms and the antimicrobial susceptibility
patterns. Although antibiotics have significantly improved human health, many resistances
to the antibiotics such as ampicillin, gentamicin, and ciprofloxacin (first-line antibiotics)
are developed in the case of an inappropriate choice of the antibiotic, a shorter or extended
application, or even a low concentration of the antimicrobial agent [9,23]. Consequently,
infected chronic wound control has become an increasing health problem and has made
it difficult to select appropriate antibiotics for treatment. In recent years, the resistance of
bacteria to antibiotics has become more and more evident, which is a cause for concern in
the health sector [24]. Because antimicrobial resistance is on the rise, there is an emerging
demand from research around the world to explore new alternatives. Several recent de-
velopments in wound care have focused on integrating different antimicrobial agents in
combined physical current therapies, for chronic wound infections [24].
Due to all possible impairments on the healing process, there are different available
treatments for chronic wounds—from the traditional wound care management to the new
and innovative therapies developed recently [9,22]. As with acute wounds, the debridement
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and the use of wound dressings in chronic wounds are considered a traditional and crucial
method of local wound management in order to minimize infection and remove excess
exudate and foreign material from the wound bed [8]. Debridement can also be performed
using negative pressure therapy, which consists of the removal of exudates by vacuum
devices [25]. Another approach for local wound management is hyperbaric oxygen therapy,
which increases the production of growth factor and collagen and reduces the presence
of pro-inflammatory enzymes [26]. For the same purpose, electrical stimulation consists
of current pulses of electromagnetic energy. As regards relevance to improve the healing
process, electrical stimulation can increase fibroblasts stimulation and enhance collagen
production. In order to improve wound management further, new therapies have been
recently proposed by the scientific community, such as ultrasounds. Ultrasounds have
shown to be able to reach deep-seated tissues due to being highly orienting and low
scattering. Despite the fact that further testing and standardized treatment protocols were
required, great results in diabetic ulcer treatment were achieved [2].
Overall, most physical therapies are expensive, making it impossible to be used in
large numbers because not all hospitals have the resources to implement them. Despite the
regular need for dressing changes, dressing treatments are still the most used therapy
for wound care due to their low price and several characteristics as wound healing pro-
moter [27,28].
2.3. Challenges and Promising Dressings
Nowadays, new strategies for wound care are studied in order to reduce inpatient
costs and provide an effective healing process and long-term relief [29]. When in contact
with a chronic wound, the goal of any chronic wound dressing is to control the infection
if present, through antimicrobial agents, but the biomaterial should also have proper me-
chanical properties, be biocompatible and non-toxic, remove excess exudates, be easily
removed without causing trauma, create a proper moisture balance in order to acceler-
ate the healing, provide a matrix for cell migration, and stimulate extracellular matrix
deposition. However, there is no perfect wound dressing that embraces all necessary
requirements. The effectiveness of a given dressing depends on the type of the wound,
wound history, the applied treatment to date, and the frequency of the dressing change.
All these parameters must be assessed. Wound dressings are classified according to the
interaction with the wound—passive/inert dressings (immediately available for acute
wounds) and bioactive/interactive dressings (bioactive compounds are incorporated to
promote wound healing and protect wounds from infections) [9]. There are different types
of wound dressings, such as hydrocolloids, films, foams, sponges, membranes, alginates,
nanofibers, or hydrogels [30,31]. All these distinct dressings have different properties that
make them appropriate for a particular type of wound. Hydrocolloids are constituted
by hydrophilic polymers (colloid particles) dispersed in water. As occlusive and moder-
ate absorptive dressings, hydrocolloids are suitable for both acute and chronic wounds.
However, some hydrocolloids can be difficult to remove and cytotoxic. Thus, this type of
dressing is not ideal for infected wounds and for diabetic foot ulcers [32,33]. Foams are
non-adherent, easy to remove, and highly absorbent dressings that are able to provide a
moist environment to the wound. As hydrocolloids, foams are appropriate for the treat-
ment of granulated wounds with a mild to moderate exudate once the granulation tissue is
maintained, and the epithelialization is improved [34]. Hydrogels can also be applied in
granulated/epithelializing wounds and in wounds with eschar, as in the case of Vigilon®
(Bard Home Health Ltd., Berkley Heights, NJ, USA). On the other hand, hydrogels are
unsuitable for highly exuding wounds due to a possible maceration [35,36]. Hydrogels are
three-dimensional, cross-linked polymeric networks with a huge capacity to store high
amounts of water. Non-adherence, high exudates capacity, biocompatibility, easy removal,
healing properties, and low cost are considered as advantages of hydrogels in wound care.
Nonetheless, their weak mechanical properties and their poor bacterial barrier represent
some disadvantages of hydrogels [37,38]. Recently, to avoid the formation of fluid pockets
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that enable the proliferation of bacteria, easy powders able to create in situ hydrogels have
been suggested for wound care. Under physiological conditions, the powder can transform
into a gel form by different mechanisms, including ionic cross-linkage, temperature modu-
lation, and pH change, without the necessity to use external gelling agents. As advantages,
in situ gelling system can cover some limitations of performed gels. This system provides
easily dropped preparations and enables a more efficient and focused application in the
wound site. An in situ gel-forming system composed of Pycnogenol® (Horphag Research
Ltd., Switzerland, UK), a food supplement rich in phenolic compounds used for various
medical purposes was evaluated in terms of wound healing activity. Results revealed that
Pycnogenol loaded in situ gel exhibited remarkable wound healing activity and showed a
significant effect on angiogenesis, granulation tissue thickness, and epidermal and dermal
regeneration [39]. Sponges used as wound dressings have high porosity and are excellent
dressing to maintain a moist environment at the wound site. Sponges are also able to
provide thermal insulation at the wound site, but this type of dressing is unsuitable for
wounds with dry eschar due to its poor mechanical stability and the skin maceration that
it can cause [23,36]. In contrast, films, which are adhesives composed of a thin sheet of
polyurethane, are not absorptive dressings and cause exudate accumulation, which can
lead to maceration, causing damage on the new epidermis that meets it. For this reason,
film dressings, such as TegadermTM (3 M Healthcare, St. Paul, MN, USA) or BlisterfilmTM
(Kendall County, NY, USA), are normally used for superficial wounds with no exudate [24].
Moreover, films are also not ideal for infected wounds and require a border of dry and
intact skin for the adhesive edge of the wound dressing [32,40].
Furthermore, alginates dressings are composed of calcium salt and sodium alginic.
Alginate dressings are not appropriated for dried wounds because alginate needs moisture
for its efficient performance [41]. Therefore, their non-adherence, high mechanical stability,
stability for a long period of time, and high absorbance, make alginate dressings ideal
for exudating wounds [37]. In turn, membranes are occlusive and microporous wound
dressings with the purpose to reproduce the three-dimensional architecture of the native
extracellular matrix and act as physical barriers. Their architecture promotes cell prolif-
eration, nutrient supply, and control fluid loss. In addition, membranes have been used
in wound healing due to their biocompatibility and mechanical properties [42,43]. Nev-
ertheless, some drawbacks are associated with membranes, such as the need for frequent
substitution, leading to an increased risk of wound infection, limited drainage capacity,
and exudate accumulation [43]. Nanofibers are composed of natural or synthetic polymers,
forming a promising matrix with several advantages, such as a highly specific surface area
and small diameter. They have been extensively studied for diabetic wound application
due to their healing properties, such as the capacity to promote the absorption of exudation
and the exchange of oxygen, water, and nutrient [44,45].
3. Bio-Based Antimicrobial Agents and Wound Dressings for Healing and Infection
Control
Antimicrobial wound dressings are applied to prevent wound contamination and
treat wound infections by protecting the wound from microbial penetration and killing
the invading microorganisms, respectively. In addition, antimicrobial dressings are also
able to improve the healing process by promoting fibroblast migration [2,35]. Currently,
in an attempt to improve their antimicrobial properties along with antibiotic resistance,
different natural compounds (inorganic compounds, honey, plant compounds, and natural
polymers) and micro and nanoparticles were studied as potential antimicrobial agents to be
incorporated in wound dressing [23]. So far, some inorganic antibacterial materials, such as
silver and zinc oxide, are being studied and used to enhance wound fessing properties.
Stojkovska et al. prepared a silver/alginate nanocomposite hydrogel and performed
in vitro functional evaluation, with results showing antimicrobial activity against S. aureus
and E. coli [2]. Likewise, zinc oxide nanoparticles-loaded-sodium alginate-gum acacia was
studied by in vitro wound healing against sheep fibroblast cell culture and antimicrobial
tests, showing promising results [2]. On a smaller scale, copper is also being studied as
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an inorganic material with antimicrobial activity to be incorporated in wound dressings
for wound care [30,46]. Antimicrobial activity of copper-based dressings was already
tested and proven against E. coli and S. aureus [47]. In recent years, honey has also shown
antimicrobial properties to improve the healing process of chronic wounds by minimizing
inflammation and stimulating angiogenesis and epithelialization [2]. A study evaluated the
antimicrobial properties and wound healing activity of honey by in vitro and in vivo assays,
demonstrating the capacity to inhibit Pseudomonas aeruginosa, S. aureus, Klebsiella pneumonia,
and Streptococcus pyogenes. Furthermore, in the same study, great wound healing properties
in burn-induced wounds in mice were also demonstrated [48]. Nowadays, there are already
a few wound dressings for chronic wounds available in the market, such as Algivon®
(Advancis Medical, Nottinghamshire, UK) and MediHoney® (Derma Sciences, Plainsboro,
NJ, USA), in which honey is the agent responsible for the antimicrobial activity [23].
In other respects, essential oils have also spurred interest as a source of antimicrobial agents
that can be used in the treatment of chronic wounds. Henna (Lawsonia inemis) [49,50]
and essential oil of Hypericum perforatum [51] are two examples that are being studied as
potential natural antimicrobial agents to functionalized wound dressings against S. aureus
and E. coli. Liakos et al. studied the antimicrobial potential of cellulose-based fibrous
dressings with different essential oils, including cinnamon, lemongrass, and peppermint,
revealing a potential capacity of the dressing to inhibit the growth of E. coli [52].
The specific advantage of these essential oil compounds may be related to a synergistic
effect of their components, with greater activity when applied as natural essential oils,
compared with the effects of the individual compounds [53]. The activity of the main
components could be raised by minor molecules present in essential oils composition [53].
In this sense, a number of reports established a link between strong antibacterial activity
and the presence of monoterpenes, eugenol, cinnamaldehyde, carvacrol, and thymol in
essential oils [54,55]. Other components, such as sesquiterpenoid bisabolol, nerolidol,
farnesol, and apritone compounds have also been explored as traditional antibiotics for
their ability to enhance the bacterial permeability and susceptibility of several strains
(i.e., E. coli and S. aureus) to exogenous antimicrobial agents by affecting the membrane
permeability of these bacteria [56].
4. Polyphenol-Based Systems and Their Unveiling Potential for Wound Care
Despite the search for natural antimicrobial compounds as a response to the need
of finding effective alternatives to traditional antibiotics and enhancing the antimicrobial
potential of wound dressings, there is also interest in the antioxidant activity of certain
natural formulations. In fact, this property is also valuable in reducing the oxidative stress
of chronic wounds.
Polyphenols have generated great interest in wound treatment due to their antimicro-
bial capacity and their regenerative and antioxidant properties [19,57]. They are normally
extracted from plants and marine organisms. There are more than 8000 different polyphe-
nols described in the literature, which are divided into two main subgroups—flavonoids
(e.g., flavonols and anthocyanidins) and non-flavonoid compounds (e.g., phenolic acids,
tannins, and lignans), depending on the number and binding structure of phenol units [58].
Polyphenols have been of great interest for medical and pharmaceutical applications, in
particular in wound care [19]. Generally, polyphenols are known to have high antioxidant
activity, providing protection against ROS through the neutralization of free radicals by
donating an electron or a hydrogen atom. Moreover, some polyphenols have also antimicro-
bial activity against certain bacteria present in infected chronic wounds [57]. Although the
mechanisms of antimicrobial activity of polyphenols are not yet fully deciphered, it is
believed that it might be associated with the disintegration of the bacterial cell wall through
hydrophobic components of phenolic compounds, the changes in intracellular functions
by hydrogen binding of these bioactive compounds to enzymes, or by the modification of
the cell wall rigidly with integrity losses due to different interactions with the cell mem-
brane [19]. Therefore, the enhancement of the lipophilic character of polyphenols increases
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their antimicrobial activity [59]. In addition, the antimicrobial potential of polyphenols
was already reported as being especially significant against strains resistant to antibiotics,
such as methicillin-resistant S. aureus [9].
4.1. Antimicrobial Polyphenol Wound Dressings
Given the antimicrobial and antioxidant potential of polyphenols, it is believed that
phenolic compounds can be great bioactive agents to be incorporated in wound dressings
for chronic wound treatment, playing a key role in wound care. There are already some
studies that validate the use of polyphenols with antioxidant or/and antimicrobial prop-
erties to promote wound healing (Table 1). Thymol, a polyphenol, was incorporated into
different wound dressings, such as films and hydrogels, due to the antioxidant and antimi-
crobial potential of the phenolic compound, revealing great results as a wound healing
promoter [60]. Along the same lines, kaempferol, chlorogenic acid, resveratrol, and ferulic
acid are some examples of phenolic compounds with great antioxidant properties to pro-
mote wound healing in chronic wounds. Tannic acid is a tannin with interesting properties,
such as antioxidant, antiviral, hemostatic, anti-inflammatory, anticarcinogenic, and an-
timicrobial activities. The use of tannic acid as a bioactive compound for the treatment of
wounds and skin ulcers has already been proved. Nurettin Sahiner et al. [61] prepared an
antioxidant and antimicrobial hydrogel composed of free tannic acid by using trimethylol-
propane triglycidyl ether as a cross-linker for chronic wound application. This study was
the first and only one related to a fully polyphenolic hydrogel to be used as wound heal-
ing for chronic wounds. Through minimum inhibition concentration values, the wound
dressing displayed antimicrobial activity against P. aeruginosa, S. aureus, Bacillus subtilis,
and Candida albicans. In another study, antibacterial tannic acid metallogels were developed
as infected wound dressings with responsive properties. The metallogels were synthesized
via co-gelation of tannic acid, high-oxidation state titanium ions (TiIVs), and antimicrobial
metal ions for the formation of three-dimensional metal-phenolic networks (MPNs) [62].
The antimicrobial metal ions of ZnII, CoII, NiII, FeIII, and CuII were included in the met-
allogels to evaluate the release profiles, cytotoxicity, and antimicrobial potency. The best
results were achieved for TA–TiIV–CuII metallogels as antimicrobial dressing, indicating
healing in the wound area and the infection control, compared to TA–TiIV gels and gauze.
The smart formulation was revealed to be a promising and potential material for medical
applications. Tan et al. [63] also anchored tannic acid/Ca (II) on the surface of chitin
nanofiber sponge by layer-by-layer deposition based on the coordination complex of tannic
acid and Ca2+. The results revealed that these chitin nanofiber sponges anchored TA/Ca
(II) coating had rapid hemostatic and antibacterial properties, which may have great po-
tential to design hemostatic products in biomedical application. In a different perspective,
Xu et al. [64] developed biocompatible tannic acid (TA)/chitosan (CS)/pullulan (PL) com-
posite nanofibers (NFs) with synergistic antibacterial activity against E. coli. The NFs were
developed utilizing the forcespinning® (FS) technique from CS–CA aqueous solutions to
avoid the usage of toxic organic solvents. These new NFs favored the fixation and growth
of fibroblasts, providing a 3D environment that promises to imitate the extracellular matrix
(ECM) in the skin. They were also capable of allowing cells to move through the fibrous
structure, enhancing interlayer growth across the membrane and the consequent deep and
intricate wound healing. In terms of healing properties of the polyphenol, a very recent
study evaluated wound healing properties of free tannic acid by in vitro and in vivo tests,
and results revealed that the tannin was able to accelerate re-epithelization and increase
hair follicles [65]. Thus, once the healing properties of tannic acid are known, it is expected
to have great potential in its incorporation into biomaterials for wound care as a natural
antimicrobial and antioxidant agent for chronic wounds [64].
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Curcumin is a hydrophobic polyphenol compound with antimicrobial [76], antioxi-
dant [60], and wound healing properties [66]. In a study by Krausz BA et al. [60], silane com-
posite nanoparticles were produced to incorporate curcumin in a porous lattice. The sam-
ples were prepared by a sol–gel-based polymerization technique and it was reported
that nanoparticles were able to inhibit S. aureus MRSA growth and P. aeruginosa and
enhance wound healing in a murine wound model. Anjum et al. [77] developed a com-
posite material for wound dressing containing nanosilver nanohydrogels (nSnH) with
aloe vera and curcumin that promote antimicrobial nature, wound healing, and infection
control. Nanosilver nanohydrogels were synthesized by nanoemulsion polymerization
Appl. Sci. 2021, 11, 1230 11 of 20
of methacrylic acid (MAA), followed by subsequent crosslinking and silver reduction
under irradiation. Rapid healing was observed in wounds treated with this nSnH gel
on scars compared to the other groups. Histological studies have shown that aloe vera
dressings are the most suitable. These results suggest that nSnH, together with aloe vera
dressing material, may be promising candidates for wound dressings. Bajpai et al. [78] pre-
pared curcumin-loaded chitosan/cellulose microcrystals composite films by vapor-induced
phase inversion (VIPI) method. This study revealed that the Ch/CMC films loaded with
curcumin demonstrated a controlled release of Cur for a period of 36 h. The amount of
curcumin released showed a negative dependence on the concentration of cellulose crystals
dispersed in the chitosan matrix. The scattered CMC produced additional physical cross-
links and slowed the release rate. The films showed reasonable antimicrobial activities
against different bacteria and fungi.
Despite all promising properties, polyphenols have certain limitations, including in-
stability, low aqueous solubility, weak bioavailability, light sensitivity, and limited mem-
brane permeability [79]. Consequently, polyphenols are easily oxidized by light exposure,
which makes their use and handling limited, also due to their reactivity and their limited
absorption and delivery into targeted tissues. Moreover, the concentrations of phenolic
compounds that are effective in vitro tests are not often enough for in vivo studies [80].
Thus, as a means to overcome these drawbacks, encapsulation of polyphenols as an efficient
delivery system is believed to be the solution to overcome this problem, improving the sta-
bility of polyphenols and controlling their delivery and release [81]. Different studies that
compared the activity of the encapsulated polyphenol to its free form concluded that effects
were greater for encapsulated compounds [82–84]. Curcumin incorporated in hydrogel
for diabetic wound application was studied. Because curcumin has both low bioavail-
ability and in vivo stability, as do most polyphenols, gelatin microspheres were used to
encapsulate the phenolic compound in order to overcome its limitations. Through mi-
croencapsulation, obtained results revealed the capacity to significantly promote skin
wound healing of the delivery system with curcumin. Similarly, despite the potential
health benefits of resveratrol, polyphenol is a difficult compound to be incorporated into
commercial pharmaceutical products due to its poor water solubility, low bioavailability,
and chemical instability. In this sense, nanoparticulate systems using pectin as a wall mate-
rial were investigated in order to protect and deliver the phenolic compounds. Antioxidant
results showed higher values of antioxidant activity encapsulated resveratrol compared to
free resveratrol.
4.2. Polyphenol Encapsulation Techniques
Due to the polyphenols’ reactivity, encapsulation technology plays an important role
to protect and stabilize phenolic compounds. The encapsulation process is characterized
as the technique by which bioactive compounds are entrapped into coating materials or
encapsulation matrices [61]. The applications of encapsulation are exponentially increasing
due to its high potential, and nowadays, encapsulation is used in many scientific and
industrial domains, such as biomedical, cosmetic, food, veterinary, textile, agriculture,
pharmaceutical, and chemical industries.
The rationale for creating an encapsulation system can be (i) protection of the encapsu-
lated material against environmental factors including UV rays, moisture, and oxygenated
environment, (ii) promotion of a controlled release of the encapsulated compound, (iii) con-
tribution to an increase in the shelf life of the product, (iv) reduction of bioactive compound
needed at the target site, and (v) structuration and functionalization of the product [61].
The coating material is a vital component in any encapsulation process. An appropriate
wall material determines the physical and chemical properties of the resultant micro or
nanoparticles. Different materials can be used as encapsulating materials, such as proteins,
lipids, gums, and natural or synthetic polymers [85].
Micro and nanoencapsulation of polyphenols have been continually explored in order
to increase their bioavailability in several potentials in food and pharmaceutical industries,
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in addition to their therapeutic potentials in healthcare. Both techniques involve the forma-
tion of active-loaded particles with regular (spherical, oval, and tubular) or irregular shapes
and diameters ranging from 1 µm to 1000 µm, in case of microparticles, and from 1 nm to
1000 nm in nanoparticles [86]. In terms of morphology/structure, particles can be classified
as capsules or spheres. Generally, both terms are considered and mentioned as being equal,
but theoretically, they have different morphologic characteristics. While capsules are de-
scribed as a vesicular or reservoir system, where the shell is around the core (or an outside
layer), spheres are characterized as a matrix type, where the core material is distributed
homogeneously or heterogeneously into the outside layer. A few encapsulation methods
have been developed on micro- and nanoscales. There are different techniques used for
encapsulation of polyphenols—the spray drying, electrospinning, liposomes, coacervation,
and inclusion encapsulation being the most used methods [86]. The choice of the most
suitable technique must be studied based on decisive factors, including the type and the
size of particles desired, the application of the product, physicochemical properties of both
the core material and the encapsulating agent, the type of controlled release, the production
scale, and the cost.
The spray drying method is one of the most used techniques for the encapsulation
of polyphenols. Spray drying is a process based on the transformation of a liquid feed,
which is composed of a certain active agent with a chosen coat material, in dry particles
by atomizing the feed in a flow of hot air [81]. This method is characterized by the ability
to decrease the water activity, avoid degradation processes, and ensure microbiological
stability [87]. For all the advantages of the encapsulation method, spray drying is one
of the most used methods to produce microparticles in the pharmaceutical industry and
laboratory applications, and the most suitable method for the encapsulation of hydrophilic
and hydrophobic phenolic compounds obtained from plant sources. Different polyphenols
encapsulated by the spray drying method were already studied, such as procyanidins,
tannins, olive leaf extract, and anthocyanins. Electrospinning is also a versatile processing
tool that can allow for the effective encapsulation of polyphenols with great potential for
wound healing, as revised by Vilchez et al. [88]. Nanofibers have numerous advantages,
such as the possibility to use mild processing conditions and controlled biodegradability
(seconds to months) as carriers in a solid dosage. In addition, it is possible to control the
architecture of the fiber at macroscopic levels and manufacture core-shell morphologies,
multilayer structures, and various three-dimensional geometries [89–91]. Liposomes are
colloidal particles consisting of a bilayer membrane system formed by the self-assembling
of phospholipids [92]. Normally, this technique is used to protect the bioactive compound
from digestion in the stomach, leading to the enhancement of its bioactivity and bioavail-
ability. As an example, curcumin was encapsulated in liposomes in order to overcome the
poor absorption of the polyphenol from the gastrointestinal tract after oral administration.
The results of the study revealed that curcumin enhanced gastrointestinal absorption by
liposome encapsulation [93,94]. Likewise, liposomes were revealed to be great candidates
for the delivery of kaempferol and quercetin [95]. Coacervation is also a technique used for
the encapsulation of polyphenols, which involves the interaction of oppositely charged
polyelectrolytes in aqueous form. However, coacervation is more expensive than the lipo-
some method [93]. On the other hand, inclusion encapsulation is widely used to improve
the water solubility of polyphenols. Generally, cyclodextrins are the most used compounds
as encapsulating material. Evidence of the effectiveness of the inclusion technique in
encapsulating polyphenols and improving their solubility, including resveratrol [96,97],
curcumin [98], chlorogenic acid [99], and kaempferol [100], has been reported by a num-
ber of researchers. Each encapsulation method has its own advantages and limitation,
which should be considered according to the application and the purpose of the final
product (Table 2).
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Table 2. Advantages and limitations of some encapsulation methods applicable for polyphenols.
Method Underlying Mechanism Advantages Limitations References
Spray drying
Transformation of a liquid
feed in dry particles by
atomizing the feed in a
flow of hot air.
Simple, flexible, rapid,
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Independently of the encapsulation method used, the selection of an appropriate
encapsulating material is extremely important to achieve the required final characteristics,
such as a desirable encapsulation efficiency and particle stability. An ideal choice of the
wall material should respect the following criteria [81,102]: (i) the encapsulating agent
should have a low viscosity and should provide good protection to the core material, (ii) the
properties of coated material (porosity and solubility), (iii) the encapsulation efficiency,
toxicity, and microscopic properties of the surface of the particles, (iv) the compatibility
between both materials, i.e, the encapsulating material should not react with the core,
(v) the microencapsulation process, (vi) the desired size for the particles, and (vii) the
required application of micro- or nanoparticles and economic factors.
4.3. Natural versus Synthetic Polymers for Polyphenol Carrier Design
The physicochemical properties of a particle wall play a decisive role in its perfor-
mance. Therefore, certain factors have to be taken into consideration in the selection of
coating material, including (i) the ability for providing protection to the core material
against the environmental conditions, (ii) the capacity for providing a controlled release of
the active compound, (iii) the viscosity (ideally moderated), non-toxicity, and biodegradabil-
ity of the compound, and (iv) the compatibility between encapsulated and encapsulating
(the wall material should be inert toward core active compound) [81,102]. Different poly-
mers have played an important role in the advancement of microencapsulation technology
by successfully ensuring the controlled release of active compounds and by providing
an intrinsic therapeutic benefit. Both synthetic and natural polymers can be used as
encapsulating agents [103,104].
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Examples of common synthetic polymers used in microencapsulation include poly-
lactides (PLAs), polyglycolides (PGAs), and poly(lactide co-glycolides (PLGAs) [105].
As advantages, synthetic polymers are modified more easily, with tunable properties,
and can provide greater chemical and mechanical stability and reduced nonspecific pro-
tein binding. On the other hand, synthetic polymers can be toxic and non-degradable
compounds [105].
Natural polymers have attracted the interest of the scientific community for wound
care, such as wound biosensors, drug carrier and delivery systems, tissue engineering,
and wound dressings [106]. Contrary to synthetic polymers, biopolymers are biodegrad-
able and present enhanced biocompatibility. In addition, biopolymers allow the adhesion
to target tissues, provide a neutral coating with low surface energy, are compatible with the
environment, and possess specific receptor recognition [104]. However, there is a consider-
able level of variability among polymers derived from animal sources. On the other hand,
their extraction process can be complicated and costly [103]. Chitosan, hyaluronic acid,
and alginate are examples of natural polymers commonly used in microparticulate sys-
tems for skin wound dressing and drug delivery [104]. Chitosan is one of the most used
polymers as coating materials due to its cationic character based on its primary amino
groups, which gives it extraordinary properties, such as controlled drug release, in situ
gelation, and mucoadhesion [107]. Moreover, chitosan is also characterized by its excel-
lent hemostasis capability and antimicrobial, antifungal, and antiulcer properties [107].
This non-toxic and biocompatible polymer is considered a safe material by the United States
Food and Drug Administration (FDA), and it is one of the most used biopolymers both in
pharmaceutical and biomedical applications, including the wound healing area and tissue
engineering [107,108]. Chitosan-based hydrogels were shown to influence all four stages of
wound healing by regulating the migration of neutrophils and macrophages, suppressing
the infiltration of inflammatory cells, improving the inflammatory function of leukocytes,
and accelerating fibroblast proliferation [109–111]. Although commercial chitosan-based
hydrogels using microparticles were found, commercial chitosan-based wound dressings
for chronic wounds are already available, such as Tegasorb® (3M Science Applied to Life,
USA) and Chitoflex® (HemCon Medical Technologies, Portland, OR, USA) [110]. Differ-
ent drugs, such as growth factors, antimicrobial agents, hormones, antifungal, and stem
cells can be incorporated into chitosan microparticles in order to improve the efficacy of
their properties [110,112]. Chitosan microparticles have also offered great promise in topi-
cal applications, and recently, this polymer has been studied as an encapsulating material
for polyphenols [81]. Curcumin was encapsulated into chitosan/poly-y-glutamic/pluronic
nanoparticles by Lin et al. for the local treatment of wounds. The authors proved the
encapsulation of the polyphenol ensured a controlled release in phosphate buffer solution,
simulating the wound exudate [113]. On the other hand, hyaluronic acid is a biocompatible,
biodegradable, and non-toxic hydrophilic polymer. As chitosan, hyaluronic acid has also
been used in tissue engineering and wound care due to its antimicrobial, antioxidant,
and anti-inflammatory activities. Moreover, hyaluronic acid is known to bind to the com-
ponents of the extracellular matrix that undergoes remodeling during regeneration [114].
However, when applied to the wound, hyaluronic acid has the disadvantage of reduced
wound breathability [115]. In order to overcome this drawback, a hydrogel composed of
hyaluronic acid and poloxamer was developed and studied, revealing excellent results in
terms of air permeability, promoting skin-wound healing and increasing protein accumula-
tion, and isolating skin wounds from bacterial invasion [116]. The use and effectiveness of
hyaluronic acid as a coating material of micro- and nanoparticles in wound care was already
studied and proved [117–119]. As an example, Sun-Woong et al. developed microparticles
of hyaluronic acid with epidermal growth factor by emulsion for the purpose of targeted
and sustained epidermal growth factor delivery to damaged extracellular matrix in acute
wounds [117]. Studies of polyphenols-loaded hyaluronic micro or nanoparticles were not
founded. However, wound healing efficacy of curcumin conjugated to hyaluronic acid was
studied, exhibiting higher values of antimicrobial and antioxidant activity and migration
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of cells in scratch wounds compared to treatment with native curcumin [120]. These results
suggest that hyaluronic acid conjugation with curcumin is a promising formulation for
enhancing its healing efficacy.
5. Conclusions
Chronic wounds are complex, and the current therapeutic approaches do not fully
address the needs of this condition. As presented in this study, there is an emerging de-
mand to explore natural, biodegradable, and ecological solutions as potent alternatives to
conventional antibiotics. Polyphenols have been proven to exhibit strong pro-inflammatory
activities and play an important role in recruiting inflammatory cells to the site of inflam-
mation, accelerating the entire healing process. In addition, polyphenols can promote
the proliferation and migration of endothelial cells and fibroblasts. The unquestionable
antioxidant and antimicrobial properties make these bioactive agents excellent candidates
for controlling infection and promoting healing. However, their low bioavailability and
stability represent a challenge concerning therapeutic efficacy. The different micro- and
nanoencapsulation technologies discussed here have proven to be a promising strategy
to overcome these limitations by improving the stability of polyphenols and providing a
controlled release at the wound site. Moreover, because many of these polymeric matri-
ces are from natural origin, they can provide additional bioactivity, which enhances the
therapeutic efficiency of the system. The studies reported in this review clearly reveal this
tendency on the use of micro- and nanosystems, based on encapsulation of polyphenols
with natural biopolymers as the coating material for the treatment of wounds. In the future
and through these smart delivery systems, a clear alternative to antibiotics is expected to
emerge. However, more studies still must be conducted to establish its safety, effectiveness,
and stability in dressings for different types and stages of chronic wounds. The need for
regulatory approval of these smart-bio-based wound dressings is still a long path that
needs to be taken.
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61. Sahiner, N.; Sagbas, S.; Sahiner, M.; Silan, C.; Aktaşa, N.; Turk, M. Biocompatible and biodegradable poly(Tannic Acid) hydrogel
with antimicrobial and antioxidant properties. Int. J. Biol. Macromol. 2016, 82, 150–159. [CrossRef]
62. Anh, H.T.P.; Huang, C.-M. Intelligent metal-phenolic metallogels as dressings for infected wounds. Sci. Rep. 2019, 9, 1–10.
[CrossRef]
63. Tan, L.; Zhou, X.; Wu, K.; Yang, D.; Jiao, Y.; Zhou, C. Tannic acid/CaII anchored on the surface of chitin nanofiber sponge
by layer-by-layer deposition: Integrating effective antibacterial and hemostatic performance. Int. J. Biol. Macromol. 2020, 159,
304–315. [CrossRef]
64. Xu, F.; Weng, B.; Gilkerson, R.; Materon, L.A.; Lozano, K. Development of tannic acid/chitosan/pullulan composite nanofibers
from aqueous solution for potential applications as wound dressing. Carbohydr. Polym. 2015, 115, 16–24. [CrossRef]
Appl. Sci. 2021, 11, 1230 18 of 20
65. Chen, Y.; Tian, L.; Yang, F.; Tong, W.; Jia, R.; Zou, Y.; Yin, L.; Li, L.; He, C.; Liang, X.; et al. Tannic acid accelerates cutaneous
wound healing in rats via activation of the ERK 1/2 signaling pathways. Adv. Wound Care 2019, 1, 341–354. [CrossRef] [PubMed]
66. Liu, J.; Chen, Z.; Wang, J.; Li, R.; Li, T.; Chang, M.; Yan, F.; Wang, Y. Encapsulation of curcumin nanoparticles with MMP9-
responsive and thermos-sensitive hydrogel improves diabetic wound healing. ACS Appl. Mater. Interfaces 2018, 10, 16315–16326.
[CrossRef] [PubMed]
67. Koosehgol, S.; Ebrahimian-Hosseinabadi, M.; Alizadeh, M.; Zamanian, A. Preparation and characterization of in situ chi-
tosan/polyethylene glycol fumarate/thymol hydrogel as an effective wound dressing. Mater. Sci. Eng. C 2017, 79, 66–75.
[CrossRef]
68. Jiji, S.; Udhayakumar, S.; Rose, C.; Muralidharan, C.; Kadirvelu, K. Thymol enriched bacterial cellulose hydrogel as effective
material for third degree burn wound repair. Int. J. Biol. Macromol. 2019, 122, 452–460. [CrossRef] [PubMed]
69. Kavoosi, G.; Dadfar, S.M.M.; Purfard, A.M. Mechanical, physical, antioxidant, and antimicrobial properties of gelatin films
incorporated with thymol for potential use as nano wound dressing. J. Food Sci. 2013, 78, E244–E250. [CrossRef]
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